clairop

Should I Get My Colon Removed? Ulcerative Colitis

Colectomy ends colitis in the colon but is a trade, not a cure-all. When guidelines advise it, what outcomes look like, and what to ask your surgeon.

Clairop Team20 min read

Photo: Blake Wisz / Unsplash

The short answer

A colectomy removes the colon that ulcerative colitis lives in, and guidelines advise it for severe attacks that fail rescue treatment, complications, cancer risk, or chronic disease that medicines do not control. Most people in large series report good quality of life, but complications and pouch problems are real. It is a trade, decided with your IBD team and a colorectal surgeon.

Trying to find your triggers? Clairop logs meals, symptoms and stool in seconds on iPhone, then flags foods your gut reacts to, including delayed reactions.

Get it on the App Store

Should you get your colon removed for ulcerative colitis? It depends on which situation you are in. A colectomy removes the large bowel, the organ ulcerative colitis (UC) inflames, and guidelines advise it for a severe attack that fails rescue treatment, a complication such as perforation, cancer risk, or chronic disease that medicines are not controlling. For most people it is never needed. For some it is the best option available. This article is about weighing it, not about whether you qualify.

Two other posts on this site cover neighbouring ground, so we point to them rather than repeat them. How do you know if you need a colectomy? sets out the clinical thresholds in detail, and life after colectomy for ulcerative colitis covers what comes afterwards. This one is the decision itself: the numbers on both sides, what the evidence can and cannot tell you, and how to walk into a surgical consultation prepared.

When do guidelines say you should get your colon removed?

The British Society of Gastroenterology (BSG) says surgery in a severe attack is indicated when the disease is medically resistant, medicine side effects are intolerable, or there is life-threatening bleeding, toxic megacolon or perforation. For long-standing disease it suggests offering surgery when symptoms stay active despite optimal medical therapy. Cancer risk is a third, separate route (Lamb 2019).

In plain terms, three situations put colectomy on the table:

SituationWhat it looks likeHow much choice you have
EmergencyA severe flare that does not respond to intravenous steroids and rescue medicine, or toxic megacolon, perforation or major bleedingLittle. Decided over days
Refractory diseaseSymptoms stay active despite optimal medical therapy, you cannot come off steroids, or drug side effects are not tolerableConsiderable. Planned over weeks to months
Dysplasia or cancerPrecancerous change that cannot be removed through the scope, or cancerModerate. Planned after expert review

The BSG puts the evidence behind its chronic-disease recommendation at very low quality and weak strength (agreement 94.4%), which is honest about how hard this question is to test (Lamb 2019). The European guideline body, ECCO, published surgical guidelines for UC in 2022 and updated them in 2026 (Spinelli 2022; Adamina 2026). We read the BSG full text and the abstracts of the ECCO papers, so we cite ECCO only for what it covers, not for specific thresholds.

For the exact thresholds, steroid dependence definitions and the dysplasia pathway, see how do you know if you need a colectomy?. The rest of this article starts where that one stops: assuming you are in the second situation, refractory disease, how do you decide?

What percentage of people with ulcerative colitis get their colon removed?

Most do not. A systematic review of population-based cohorts found the 5-year and 10-year cumulative colectomy risk after diagnosis is about 10% to 15%, and a 32,108-patient Finnish registry found lower figures of 4.7% at five years and 7.3% at ten. The rate has been falling since biologics arrived (Fumery 2018; Kontola 2025).

Both findings matter for your decision. The review also found that about 10% to 15% of people have an aggressive disease course, and that achieving mucosal healing is associated with a lower risk of colectomy (Fumery 2018). The Finnish study found risk fell in the later era compared with the pre-biologic era, though the risk among older adults stayed constant, and men and children had a higher risk than women and adults (Kontola 2025).

So the honest base rate is that colectomy is the minority path. If your own course is not the minority one, with repeated steroid courses and several failed drugs, these averages stop describing you. They are the context, not your odds.

Is it worth it? What the outcome evidence shows

In the largest pouch series published, 95% of patients had good or excellent function and quality of life, but there is no randomized trial comparing surgery with continued medical therapy, so "worth it" rests on cohort data and personal values. The BSG makes the same point: comparisons are difficult because there are no published comparative data, and without randomization selection bias is unavoidable (Lamb 2019; Fazio 2013).

Here is what the main studies found, and what each can and cannot show.

  • A Cleveland Clinic series of 3,707 pouch patients over 1984 to 2010 reported good or excellent function and quality of life in 95%, with perioperative mortality of 0.1%. Early complications occurred in 33.5% and late complications, not counting pouchitis, in 29.1% (Fazio 2013). That is a high-volume specialist center, and people who do badly may be less likely to answer a questionnaire.
  • A 1999 comparison of 46 people who had surgery and 18 treated with intravenous cyclosporine found the medically treated group scored as well as or better on several measures, including stool frequency and sleep. It is small, old, and from an era before today's drugs (Cohen 1999).
  • A Dutch study of 915 people found pouch patients had higher quality-adjusted life years (0.90) than ileostomy patients (0.84) and anti-TNF-treated patients (0.84), although the disease questionnaire scores did not differ. Only 81 had a pouch, 48 an ileostomy and 34 were on anti-TNF therapy, and it was observational (van der Valk 2015).
  • A modeling study of severe UC found early colectomy with a pouch produced almost identical lifetime quality-adjusted years to standard medical therapy (20.72 against 20.78) at lower lifetime cost. It is a simulation, and its result depended most on the assumed quality of life after the pouch (Park 2012).

Put together, the evidence supports a modest and honest conclusion. For people whose disease is truly refractory, surgery is a reasonable path to a stable life with good reported quality of life. For people whose disease might still respond to the next treatment, the evidence does not show surgery is better, and it does not show it is worse.

In r/UlcerativeColitis, people describe both sides (thread). Several who had surgery after years of failed drugs say they wish it had been offered earlier. Others say they would rather keep trying, hoping new medicines arrive. One reply in another thread (thread) makes a sharp point: people for whom surgery went well leave the group and move on, so forums over-represent people still struggling. That is a reason to read your own situation against published series, not against a thread.

What can go wrong after colon removal surgery?

The common problems are complications in the first months, pouchitis if you have a pouch, and, in a small share, pouch failure. In a US cohort of 1,331 pouch patients, pouchitis rose from 58% in the first year to 72% at ten years, and a meta-analysis put overall pouch failure at 6%. Knowing these figures is part of deciding with open eyes (Barnes 2024; Alsafi 2022).

OutcomeFigureSource and caveat
Early complications after pouch surgery33.5%Single high-volume center (Fazio 2013)
Late complications, excluding pouchitis29.1%Same series
Pouchitis58% at 1 year, 72% at 10 yearsUS electronic-records cohort (Barnes 2024)
Crohn's-like disease of the pouch10.3% within 10 yearsSame cohort
Advanced therapy after pouch14.4% at 10 yearsSame cohort
Pouch failure6% overall, 9% at 10 years or moreMeta-analysis of 26 studies (Alsafi 2022)

Three more facts belong in the weighing.

Fertility. A meta-analysis of 13 studies found the relative risk of infertility in women was 4.17 after a pouch compared with before (Sriranganathan 2022). The BSG advises that women who need an emergency subtotal colectomy discuss the timing of any pouch reconstruction because of this, including the option of delaying until after completing a family (Lamb 2019). If you are planning pregnancy, see our guides on planning pregnancy with ulcerative colitis and pregnancy with a J-pouch.

Surgeon and hospital volume. In a US national sample of 7,108 colectomies for UC, in-hospital mortality was 2.3% and morbidity 30.8%. Low-volume hospitals had higher odds of death (adjusted odds ratio 2.42) (Kaplan 2008). The BSG suggests pouch surgery be done in specialist high-volume centers, noting pouch failure rates of about 5.2% to 5.3% in such centers (Lamb 2019).

Surgery is staged. In an emergency, the usual first operation is a subtotal colectomy with end ileostomy, leaving the rectum. The BSG says a pouch should not be built in the acute setting, and timing should be at least 3 months and preferably 6 after the first operation (Lamb 2019).

Red flags after any bowel surgery, such as a stoma that changes color, no output with pain and vomiting, a fever, or a wound that opens or leaks, need prompt medical care, not waiting for your next appointment.

Ileostomy or J-pouch: which should I choose?

The BSG says a J-pouch and an end ileostomy provide equivalently good quality of life and that the choice is a matter of patient preference after counseling. Neither is the "better" operation in general. A small matched study found better body image with a pouch but similar overall quality of life and more long-term complications (Lamb 2019; Camilleri-Brennan 2003).

The matched study followed 19 pouch patients and 19 ileostomy patients. Long-term complications were 52.6% with a pouch against 26.3% with an ileostomy, and a pouch took a median of two operations against one (Camilleri-Brennan 2003). It was small and older, so treat it as a prompt for questions, not a verdict.

Patient values matter here. In a discrete-choice study of 293 people with UC, avoiding an ostomy influenced choices more than the range of drug risks offered, and people were willing to accept a greater than 5% 10-year risk of dying from lymphoma or infection to avoid one. Yet they saw a J-pouch as roughly equivalent to incompletely effective medical therapy (Bewtra 2014). Your own view of living with a stoma is a legitimate part of the decision, not a bias to overcome. Our guide to a J-pouch or an ostomy works through that choice in depth. Whether a pouch is an option for you at all is something your surgeon will assess.

What if medicines might still work?

Guidelines do not set a number of drugs you must fail first. The BSG says surgery should always be discussed as an option when a medicine fails, because response generally falls with each successive drug. That is different from saying surgery is the next step, and it leaves room for another option if you and your team judge it reasonable (Lamb 2019).

We cannot advise on any medicine, and nothing here says to keep or switch one. What the evidence offers is a way to ask better questions. In acute severe colitis, the CONSTRUCT trial of 270 people who had failed intravenous steroids compared infliximab with cyclosporine as rescue. There was no significant difference in quality-adjusted survival, and 41% on infliximab and 48% on cyclosporine still had a colectomy within the follow-up period (Williams 2016). Rescue therapy helps many people, but a large share still end up needing surgery, which is why surgeons are brought in early.

Readers in the colitis forums split here. Some say to try one more advanced therapy before deciding, and others describe having failed four biologics before surgery and being glad they chose it (thread). Both positions appear in guidelines in different forms: keep options open, and do not let months drift. For a closer look at medicine decisions, see are biologics worth it for ulcerative colitis?.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

Why does waiting too long matter in a severe attack?

In acute severe colitis, delay is associated with more complications, which is why the BSG calls for early referral and direct involvement of colorectal surgeons and stoma care teams. The guideline says early surgical input helps patients understand that colectomy is an important treatment option and not an outcome to avoid at any cost (Lamb 2019).

The evidence is observational. An Oxford series of 80 people who had urgent colectomy found those with a major complication had been on medical treatment longer before surgery (median 8 days against 5) (Randall 2010). In the US national sample, emergency patients whose surgery came more than 6 days after admission had higher odds of in-hospital death (adjusted odds ratio 2.12) (Kaplan 2008). Neither proves delay causes harm, since sicker people may wait longer, but both point the same way.

This does not apply to elective decisions. If you are well enough to be reading this at home, you are almost certainly in the planned situation, with time to ask questions, take a second opinion and gather your records.

What about colon cancer risk and ulcerative colitis?

Cancer risk rises with disease duration. A meta-analysis of 116 studies estimated the cumulative colorectal cancer probability in UC at 2% by 10 years, 8% by 20 years and 18% by 30 years. Those figures are older and average over many eras. Surveillance colonoscopy exists to catch precancerous change, and surgery for dysplasia is its own pathway (Eaden 2001).

The 2001 figures likely overstate today's risk because surveillance and treatment have improved, but they explain why long-standing extensive colitis is one reason surgeons raise the topic. If you have had dysplasia, ask your gastroenterologist whether it was completely removed and what your surveillance plan is. Not all dysplasia means colectomy, and our guide to how do you know if you need a colectomy? explains the difference.

How can a symptom log show that medical therapy has failed?

A dated log converts "it never gets better" into evidence your team can act on: stool frequency, blood, urgency, night-time trips, steroid courses, hospital stays and each medicine with its start date, stop date and reason. Guidelines define failure in terms like chronic active symptoms despite optimal therapy, and a log is how you show it (Lamb 2019).

A useful one-page record for a surgical consultation has:

  • A medicine timeline. Every drug, when it started and stopped, and whether it never worked, stopped working, or caused side effects.
  • Every steroid course, with dates, so steroid dependence is visible at a glance.
  • Admissions with dates and what was done.
  • A typical week and a bad week. Stools per day, days with blood, night-time trips, urgency, pain.
  • Impact. Work missed, activities canceled, sleep lost. This is part of the case.
  • Your own wishes. Whether a stoma is acceptable, whether you plan a family, what matters most to you.

If you track with an app, Clairop logs bleeding, urgency and night-time movements for ulcerative colitis, shows a PRO-2 score trend and exports a one-page summary for appointments. A paper diary does the same job. See how to describe stomach pain to a doctor and the PRO-2 score for ulcerative colitis for how to make the numbers meaningful. Tracking supports the conversation. It does not make the decision, and it is not a way to detect an emergency.

For a wider set of tools, see our best apps for ulcerative colitis.

What should you ask the surgeon before deciding?

Ask the surgeon to explain your operation, their experience with it and your own risks. Qualitative research found people considering UC surgery most wanted information about long-term effects, practical daily living and long-term support, and that these were the areas they felt least informed. Peer support was valued but rarely offered by professionals (Baker 2018).

Questions worth taking along:

  1. Which operation do you recommend for me, and why? Ask about a pouch, a permanent ileostomy and the staged path from each.
  2. How many of these operations do you do each year, and what are your pouch failure and complication rates?
  3. What are my own risks, given my age, steroid use, nutrition and any other conditions?
  4. Is the diagnosis secure? Ask whether anything suggests Crohn's disease, since that changes the pouch discussion. Our guide on whether UC can turn into Crohn's explains why this matters.
  5. What will recovery look like, week by week, and when could I return to work?
  6. How will this affect fertility and sex, and should timing change if I plan a family?
  7. Can I speak to a stoma nurse and to someone who has had the operation?
  8. What happens if I wait three months, and what would I look for in the meantime?
  9. Can I have a second opinion without losing my place?

Our guide on what to ask before J-pouch surgery and the questions to ask a gastroenterologist about colitis go deeper on these.

How do you decide if you are scared of the surgery?

Fear is a normal part of this decision, and wanting surgery during a bad flare is not a character flaw. Qualitative research found that people weighing UC surgery want information on long-term effects, daily life and support, so asking for a stoma nurse and a peer to talk to is a sensible first step, not a sign of weakness (Baker 2018). Threads in r/UlcerativeColitis describe someone in hospital who could not stop thinking "I just want it out", and others who said it was a horrible thing to want, which many found made things harder (thread). People also describe coming to terms with it after the last drug failed (thread).

A few things tend to help. Separate a decision made in the worst week of a flare from one made when you are better rested. Ask for a surgical opinion early, which commits you to nothing. Talk to a stoma nurse before you decide, not after. And find at least one person who has had the operation you are considering, through your IBD team or a patient charity.

What are the common myths about colon removal?

Four myths come up again and again: that surgery means failure, that it cures everything, that a pouch is always better than a bag, and that online success stories predict your result. Guidelines and cohort data contradict each of them, as below.

"Surgery is the last resort, so it means I failed." The BSG treats colectomy as an option to discuss whenever a medicine fails, not a defeat. It can be right before every drug has been tried and wrong after many have (Lamb 2019).

"Removing the colon cures everything." It removes the bowel disease in the colon. Pouchitis, symptoms outside the gut and a later Crohn's diagnosis can still occur (Barnes 2024).

"A pouch means no bag, so it is clearly better." The BSG says a pouch and an ileostomy give equivalent quality of life, and pouches carry their own complications (Lamb 2019).

"Everyone online who had it is happy, so it must be fine." As one forum reply pointed out, people who recovered well tend to leave the group, so what you read online is not a representative sample.

When should you see a doctor promptly?

Get urgent medical care for severe or worsening abdominal pain, a swollen belly, fever, heavy bleeding or persistent vomiting, and call your IBD team if your usual pattern worsens or steroid courses keep repeating. Seek urgent care for any of these, whether or not you are thinking about surgery:

  • Severe or worsening abdominal pain, or a swollen, hard belly.
  • Fever with a flare, a fast heartbeat or feeling faint.
  • Heavy or constant bleeding, or many bloody stools a day.
  • Vomiting that will not stop, or being unable to keep fluids down.
  • After surgery, a stoma that turns dark or purple, no output with pain, or a wound that opens or leaks.

Between appointments, call your IBD team if your usual pattern worsens, steroids stop working or you are cycling through repeated courses.

The honest bottom line

Colectomy is neither a failure nor a fix-all. It ends colitis in the colon and, for many people with refractory disease, brings a stable life with good reported quality of life. It also brings an operation, a recovery, possible complications and a permanent change in how your bowel works. Evidence cannot tell you which side of that trade is right for you.

What it can do is frame the questions. Know which situation you are in. Know the base rates and the risk figures. Ask for a surgical opinion early without committing. Bring a dated record of what has been tried. And keep the decision with the people who know your case: your gastroenterologist, a colorectal surgeon, a stoma nurse and you. For the next steps, read life after colectomy and J-pouch vs ostomy.

How we wrote this: we read the British Society of Gastroenterology guideline in full and the abstracts of the other papers cited, and we use forum threads only to describe what people report, never as evidence for a medical fact. No clinician has reviewed this article.

This article is general information, not medical advice. It does not diagnose, and Clairop is not affiliated with any hospital or guideline body cited.

Frequently asked questions

Does removing your colon cure ulcerative colitis?
Removing the colon and rectum removes the tissue ulcerative colitis lives in, which is why it is called curative for the bowel disease. It is not an end to follow-up. Symptoms outside the gut can persist, a pouch can become inflamed, and a minority are later rediagnosed with Crohn's disease. Ask your surgeon what to expect for your situation.
What percentage of people with ulcerative colitis get their colon removed?
In a Finnish national registry of 32,108 people newly diagnosed with ulcerative colitis, the cumulative colectomy risk was 1.0% at one year, 4.7% at five years and 7.3% at ten years, and it has fallen since the biologic era. A systematic review of population cohorts reported 10% to 15% at five and ten years. Rates vary by country and era.
When should you consider a colectomy for ulcerative colitis?
The British Society of Gastroenterology says surgery is indicated in a severe attack when disease is medically resistant, medicine side effects are intolerable, or there is life-threatening bleeding, toxic megacolon or perforation. It also suggests offering surgery to people with chronic active symptoms despite optimal medical therapy. Dysplasia or cancer is a third route. Your IBD team and a surgeon make the call.
Is life better after colectomy for ulcerative colitis?
For many people with refractory disease, yes. In a Cleveland Clinic series of 3,707 pouch patients, 95% reported good or excellent function and quality of life. But there are no randomized comparisons with medical therapy, patients choose surgery for different reasons, and complications are common. Reported satisfaction describes groups, not a promise for any one person.
What are the risks of colon removal surgery for ulcerative colitis?
In the Cleveland Clinic pouch series, early complications occurred in 33.5% of patients and late complications, excluding pouchitis, in 29.1%. Pouchitis affected 58% within a year in a US cohort and 72% by ten years. Pouch failure was about 6% in a meta-analysis. Surgery can also lower female fertility. Risks differ by operation, so ask your surgeon for your own numbers.
Should I try another biologic before having surgery?
That is a decision for you and your prescriber, and this article cannot advise on it. The BSG guideline says surgery should be discussed whenever a medicine fails, because response tends to fall with each successive drug. Asking your team what the realistic chance of the next option is, and when you will review, helps you weigh it.
J-pouch or ileostomy: which is better after colectomy?
The BSG guideline says a pouch and an end ileostomy give equivalently good quality of life and that the choice belongs to the patient. A small matched study found better body image with a pouch but similar overall quality of life and more long-term complications with a pouch. Our separate comparison walks through the trade-offs in detail.
How can a symptom log help with the colectomy decision?
A log turns 'it never gets better' into evidence: stool frequency, blood, night-time trips, steroid courses and hospital stays by date, alongside which medicines you tried and why each stopped. That is what your IBD team and surgeon need to judge whether medical therapy has truly failed. It supports the conversation. It does not make the decision.
What is the best app for tracking symptoms before a colectomy decision?
Any tracker that records bleeding, stool frequency, urgency, night-time trips, steroid courses and medicines by date will do the job, including a notebook. Clairop is built for this: it logs those items for ulcerative colitis, shows a PRO-2 score trend and exports a one-page summary for appointments. It does not recommend surgery.

Sources

  1. Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1-s106. doi:10.1136/gutjnl-2019-318484
  2. Spinelli A, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment. J Crohns Colitis. 2022;16(2):179-89. doi:10.1093/ecco-jcc/jjab177
  3. Adamina M, Kienle P, Chaparro M, Verstockt B, Minozzi S, Allocca M, et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment. J Crohns Colitis. 2026;20(6):jjag072. doi:10.1093/ecco-jcc/jjag072
  4. Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol. 2018;16(3):343-56.e3. doi:10.1016/j.cgh.2017.06.016
  5. Kontola K, Ilus T, Huhtala H, Helavirta L, Oksanen P. Risk of colectomy is decreasing among newly diagnosed Finnish ulcerative colitis patients. J Crohns Colitis. 2025;19(6):jjaf081. doi:10.1093/ecco-jcc/jjaf081
  6. Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1(1):15-24. doi:10.1016/S2468-1253(16)30003-6
  7. Randall J, Singh B, Warren BF, Travis SP, Mortensen NJ, George BD. Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications. Br J Surg. 2010;97(3):404-9. doi:10.1002/bjs.6874
  8. Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008;134(3):680-7. doi:10.1053/j.gastro.2008.01.004
  9. Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257(4):679-85. doi:10.1097/SLA.0b013e31827d99a2
  10. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis. 1999;5(1):1-10. doi:10.1097/00054725-199902000-00001
  11. van der Valk ME, Mangen MJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, et al. Comparison of costs and quality of life in ulcerative colitis patients with an ileal pouch-anal anastomosis, ileostomy and anti-TNFalpha therapy. J Crohns Colitis. 2015;9(11):1016-23. doi:10.1093/ecco-jcc/jjv134
  12. Park KT, Tsai R, Perez F, Cipriano LE, Bass D, Garber AM. Cost-effectiveness of early colectomy with ileal pouch-anal anastomosis versus standard medical therapy in severe ulcerative colitis. Ann Surg. 2012;256(1):117-24. doi:10.1097/SLA.0b013e3182445321
  13. Alsafi Z, Snell A, Segal JP. Prevalence of 'pouch failure' of the ileoanal pouch in ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(2):357-64. doi:10.1007/s00384-021-04067-6
  14. Barnes EL, Desai A, Hashash JG, Farraye FA, Kochhar GS. The natural history after ileal pouch-anal anastomosis for ulcerative colitis: a population-based cohort study from the United States. Am J Gastroenterol. 2024;119(11):2267-74. doi:10.14309/ajg.0000000000002891
  15. Camilleri-Brennan J, Munro A, Steele RJ. Does an ileoanal pouch offer a better quality of life than a permanent ileostomy for patients with ulcerative colitis? J Gastrointest Surg. 2003;7(6):814-9. doi:10.1016/s1091-255x(03)00103-3
  16. Bewtra M, Kilambi V, Fairchild AO, Siegel CA, Lewis JD, Johnson FR. Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):103-14. doi:10.1097/01.MIB.0000437498.14804.50
  17. Sriranganathan D, Poo S, Segal JP. The impact of the ileoanal pouch on female fertility in ulcerative colitis: a systematic review and meta-analysis. Colorectal Dis. 2022;24(8):918-24. doi:10.1111/codi.16123
  18. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526-35. doi:10.1136/gut.48.4.526
  19. Baker DM, Lee MJ, Jones GL, Brown SR, Lobo AJ. The informational needs and preferences of patients considering surgery for ulcerative colitis: results of a qualitative study. Inflamm Bowel Dis. 2018;24(1):179-90. doi:10.1093/ibd/izx026

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Download on the App Store

Apps for this, ranked

Free tools